Peter Messiaen
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 9
- COVID-19 Clinical Research Studies 6
- Epidemiology 15
- Sepsis Diagnosis and Treatment 4
- HIV, Drug Use, Sexual Risk 3
- Co-authors
- Jeroen C.H. van der Hilst (15 shared papers)Linos Vandekerckhove (10 shared papers)Steven Vanderschueren (2 shared papers)Bernard Lauwerys (1 shared paper)Michel Moutschen (2 shared papers)Nele Brusselaers (1 shared paper)Annemarie M. J. Wensing (1 shared paper)Monique Nijhuis (1 shared paper)
- Journals
- HIV Medicine (3 papers)Journal of the International AIDS Society (3 papers)BMC Infectious Diseases (2 papers)PLoS ONE (2 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Peter Messiaen
36 papers receiving 624 citations
Peers
Comparison fields: 5 of 88
- Virology 188
- Infectious Diseases 381
- Applied Microbiology and Biotechnology 14
- Emergency Medicine 58
- Nephrology 29
Countries citing papers authored by Peter Messiaen
This map shows the geographic impact of Peter Messiaen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Messiaen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Messiaen more than expected).
Fields of papers citing papers by Peter Messiaen
This network shows the impact of papers produced by Peter Messiaen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Messiaen. The network helps show where Peter Messiaen may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Messiaen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 82 | |
| 2 | 2016 | 73 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 48 | |
| 5 | 2012 | 41 | |
| 6 | 2016 | 35 | |
| 7 | 2014 | 32 | |
| 8 | 2016 | 29 | |
| 9 | 2020 | 25 | |
| 10 | Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study. | 2017 | 23 |
| 11 | 2014 | 21 | |
| 12 | 2015 | 18 | |
| 13 | 2023 | 14 | |
| 14 | 2020 | 11 | |
| 15 | 2012 | 10 | |
| 16 | 2020 | 9 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 8 |
About Peter Messiaen
Peter Messiaen is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Neurology, having authored 39 papers that have together received 631 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (9 papers), COVID-19 Clinical Research Studies (6 papers), Long-Term Effects of COVID-19 (4 papers), Sepsis Diagnosis and Treatment (4 papers), HIV-related health complications and treatments (3 papers) and HIV, Drug Use, Sexual Risk (3 papers). The work is most often cited by research in Virology (188 citations), Infectious Diseases (381 citations), Applied Microbiology and Biotechnology (14 citations), Emergency Medicine (58 citations) and Nephrology (29 citations). Peter Messiaen has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Jeroen C.H. van der Hilst, Linos Vandekerckhove, Steven Vanderschueren, Bernard Lauwerys, Michel Moutschen, Nele Brusselaers, Annemarie M. J. Wensing, Monique Nijhuis, Axel Fun and Inge C. Gyssens. Their work appears in journals such as HIV Medicine, Journal of the International AIDS Society, BMC Infectious Diseases, PLoS ONE and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.